Most Patients Hospitalized With COVID-19 Show at Least 1 Symptom 6 Months Post Infection
Little is known about long-term health effects of the disease as few follow-up studies have been carried out.
Read More
In Break From Trump Administration, Biden will Release all Available Vaccine Doses
A group of governors penned a letter to Health and Human Services pressing the government to distribute reserved doses.
SARS-CoV-2 Immunity Could Last Over 8 Months
Immune memory against the virus is also potential good news for vaccine developers.
Using Geographic Monitoring for Early COVID-19 Cluster Detection
GeoMEDD enhances investigation in near real-time and in the context of health system operations to a dynamic situation.
Moderna COVID-19 Vaccine Authorized by European Commission
European Medicines Agency exercises its option for increasing the confirmed order commitment by 80 million doses, bringing total to 160 million.
Increased Risk of COVID-19 Symptoms Associated with Smoking
Tobacco smokers are at a significant risk for both viral and bacterial infections of the respiratory system.
Why You Shouldn’t be Worried About the COVID-19 Vaccine Approval Process
Discussing how the approval process was different for COVID-19 vaccines and why it was safe.
Technology Aids in COVID-19 Vaccine Immunity Monitoring
Prior to public vaccination, a rapid and accurate COVID-19 antibody test will help determine the presence of neutralizing antibodies.
Review Shows More Data That COVID-19 Impacts the Brain
The Alzheimer's Association is funding the work of a consortium of experts from more than 30 countries.
Severe COVID-19 Cases Repaired With UC-MSC Transfusion
The findings have important implications for studies in other diseases such as Type 1 diabetes.
COVID-19’s Impact on Children With Disabilities and Caregivers
Early data reported a disproportionate impact of death rates and infection rates in Black, Native American, and Latinx communities.
Rhesus Macaques, Baboons and Marmosets as Models for SARS-CoV-2 Virus in Humans
Observing infections in non-human primates can help to expedite therapeutics and vaccines for COVID-19.
Explaining Severe Virus Attacks on the Lungs
Information gained has potential to contribute to future treatments for COVID-19 and other diseases
Brains of COVID-19 Patients Show Damage & Inflammation but No Infection
The virus may have been cleared by the time of death or viral copy numbers were below the level of detection.
COVID-19 Recoverees Show Sustained Cellular Immune Dysregulation
Investigative studies looking at underlying immune characteristics are needed to understand disease pathogenesis.
Virtual Screening Identifies Therapy that Inhibits Covid-19
Investigators developed a hybrid protocol to search for potential drug candidates against the replication of SARS-CoV-2.
Promising Mini Antibodies Against COVID-19 Isolated
Anti-COVID-19 nanobodies may potentially be effective at preventing and diagnosing infections.
NIH Sponsored ACTIV-3 Trial Results Published
Phase 3 trial data shows experimental monoclonal antibody not to be efficacious.
Understanding why COVID-19 Increases Stroke Risk
While ACE2 expression has been reported in the human brain, the cell-specific expression pattern of ACE2 is unknown.
How Coronavirus Interacts with Cells
Characterizing SARS-CoV-2 interactions can improve understanding of viral RNA functions and the host innate immune response.
Most Realistic Snapshot of Coronavirus Spike Protein Structure Viewed
The study helps to illuminate how spike proteins initiate infections.
Treatment for Ebola Virus Approved by FDA
An Orphan Drug Designation was granted to Ridgeback Biotherapeutics, LP, creator the therapy.
New COVID-19 Variant Circling the UK
Countries across Europe are reinstating travel bans and lockdowns to combat virus.
Greatest Risk Factors of Mortality from COVID-19
Healthcare providers may want to consider these risks when determining which COVID-19 patients could benefit the most from the new monoclonal antibody therapies.
FDA Authorizes Moderna’s COVID-19 Vaccine in the US
The VRBPAC voted 20-0 with 1 abstention to support the benefit-risk profile associated with mRNA-1273.
CDC Updates Treatment Guidelines for Gonococcal Infection
The CDC stressed that antimicrobial stewardship remains a major public health concern.
COVID-19 Found to Cause More Severe Disease than Seasonal Influenza
The authors note that the difference in hospitalization rate may be partly due to existing immunity to influenza in the population.
FDA Advisory Committee Votes to Support EUA for Moderna's COVID-19 Vaccine
At the interim analysis, the mRNA-1273 vaccine was found to have an efficacy of 94.5% against confirmed COVID-19.
Genes may be Key to New COVID-19 Treatments
Host genetic variants associated with critical illness may identify mechanistic targets for therapeutic development.
LED Lights Found to Kill COVID-19
UV light-emitting diodes are an emerging technology and a UV source for pathogen inactivation.